Previous 10 | Next 10 |
Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. The Mid Cap Strategy applies quantitative and funda...
Avantor® and Avantor Foundation Giving Supports Communities Around the Globe in 2022 PR Newswire Avantor and Avantor Foundation grantmaking and volunteerism advances "Science for Goodness" with focus on STEM education and healthcare access RANDOR, Pa. , Jan....
Avantor® and Catalent Enter into Multi-Year Supply and Services Agreement PR Newswire RADNOR, Pa. and SOMERSET, N.J. , Jan. 9, 2023 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to custome...
Avantor® to Report Fourth Quarter and Full Year 2022 Earnings and Host Earnings Call on Friday, February 3, 2023 PR Newswire RADNOR, Pa. , Jan. 6, 2023 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products an...
Avantor® to Participate in the 41st Annual J.P. Morgan Healthcare Conference PR Newswire RADNOR, Pa. , Jan. 3, 2023 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life scien...
Summary Halvorsen's 13F portfolio value decreased marginally from $21.86B to $21.66B this quarter. The number of positions increased from 82 to 88. Viking Global increased Elevance Health, Visa, and McKesson while decreasing T-Mobile US, Parker Hannifin, and Fortive. They also dropped A...
Avantor® to Participate in the 5th Annual Evercore ISI HealthCONx Conference PR Newswire RADNOR, Pa. , Nov. 15, 2022 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the l...
Summary Avantor, Inc. has re-rated heavily to the downside amid a vigorous selloff throughout FY22. Shares now have drifted past 2-year lows and more downside could arrive before Avantor finds a bottom. Fundamental momentum is still strong, with high FCF, ROIC and EPS upside e...
Avantor® Continues Investment to Support Biopharma Market with Opening of New Distribution Center in Dublin, Ireland PR Newswire DUBLIN , Nov. 3, 2022 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products ...
Summary Global growth stocks held up better than value, snapping a two-quarter losing streak, as global recession fears weighed more heavily on companies tied to the broader economy. The Strategy outperformed for the second quarter in a row, thanks in large part to positioning adj...
News, Short Squeeze, Breakout and More Instantly...
2024-07-29 07:15:06 ET Barclays analyst issues OVERWEIGHT recommendation for AVTR on July 29, 2024 05:42AM ET. The previous analyst recommendation was Overweight. AVTR was trading at $25.6 at issue of the analyst recommendation. The overall analyst consensus : BUY. C...
Bogota Financial Corp. (BSBK) is expected to report for Q2 2024 Capital Product Partners L.P. (CPLP) is expected to report $0.17 for Q2 2024 Colgate-Palmolive Company (CL) is expected to report $0.87 for Q2 2024 ARCA biopharma Inc. (ABIO) is expected to report for Q2 2024 Barnes G...
Avantor® Reports Second Quarter 2024 Results PR Newswire Net sales of $1.70 billion , decrease of 2.4%; organic decline of 2.0% Net income of $93 million ; Adjusted EBITDA of $306 million Diluted GAAP EPS of $0.14 ; adjusted EPS of $0.25 Op...